![]() |
|
|
Vol. 291, Issue 1, 153-160, October 1999
Departments of Anesthesia and Pharmacology, Stanford University
School of Medicine, Stanford, California (C.J.J.G.B., J.P.W.V.,
J.W.M.); and Leiden/Amsterdam Center for Drug Research, Leiden
University, Leiden, the Netherlands (C.J.J.G.B.)
This study characterizes the anesthetic profile of dexmedetomidine on
the basis of steady-state plasma concentrations using defined
stimulus-response, ventilatory, and continuous electroencephalographic (EEG) and cardiovascular effect measures in rats. At constant plasma
concentrations of dexmedetomidine (range, 0.5-19 ng/ml), targeted and
maintained by target-controlled infusion, the whisker reflex, righting
reflex, startle reflex (to noise), tail clamp response, hot water
tail-flick latency, and attenuation of heart rate (HR) increase
associated with tail-flick (sympathoadrenal block) and corneal reflex,
were assessed in 22 rats. EEG (power in 0.5- to 3.5-Hz frequency band),
mean arterial pressure, and HR were recorded continuously. Blood gas
values and arterial drug concentrations were determined regularly. The
following steady-state plasma EC50 values of
dexmedetomidine (mean ± S.E. nanograms per milliter) were
estimated: HR decrease (0.51 ± 0.04), EEG (1.02 ± 0.08),
whisker reflex (1.09 ± 0.10), sympathoadrenal block (1.85 ± 0.80), mean arterial blood pressure increase (1.99 ± 0.44), righting reflex (2.13 ± 0.15), tail-flick latency (3.65 ± 0.87), startle reflex (3.75 ± 0.64), tail clamp (5.49 ± 1.34), and corneal reflex (24.5 ± 12.3). At the EC50
value of tail clamp, ventilatory depression was minor. In rats,
dexmedetomidine creates bradycardia, sedation/hypnosis, sympathoadrenal
blocking effects, and blood pressure-increasing effects at plasma
concentrations below 2.5 ng/ml. Higher plasma concentrations are needed
to loose the startle reflex, tail-flick, tail clamp, and corneal reflex
responses. Ventilatory depressant effects are minor. The applied EEG
measure seems to reflect sedation/hypnosis but seems to have limited
value to predict the deeper levels of analgesia and anesthesia of dexmedetomidine.
This article has been cited by other articles:
![]() |
M. Naguib, M. T. Baker, G. Spadoni, and M. Gregerson The Hypnotic and Analgesic Effects of 2-Bromomelatonin Anesth. Analg., September 1, 2003; 97(3): 763 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Van Sassenbroeck, P. De Paepe, F. M. Belpaire, and W. A. Buylaert Characterization of the Pharmacokinetic and Pharmacodynamic Interaction between Gamma-Hydroxybutyrate and Ethanol in the Rat Toxicol. Sci., June 1, 2003; 73(2): 270 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-H. Li, J. S. Lohmann, H. G. Schuler, and A. J. Cronin Preservation of the Cortical Somatosensory-Evoked Potential During Dexmedetomidine Infusion in Rats Anesth. Analg., April 1, 2003; 96(4): 1155 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishizawa, R. Pidikiti, P. A. Liebman, and R. G. Eckenhoff G Protein-Coupled Receptors as Direct Targets of Inhaled Anesthetics Mol. Pharmacol., May 1, 2002; 61(5): 945 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, Z. Zhao, W. E. Code, and L. Hertz A Correlation Between Dexmedetomidine-Induced Biphasic Increases in Free Cytosolic Calcium Concentration and Energy Metabolism in Astrocytes Anesth. Analg., August 1, 2000; 91(2): 353 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. J. G. Bol, J. P. W. Vogelaar, J.-P. Tang, and J. W. Mandema Quantification of Pharmacodynamic Interactions between Dexmedetomidine and Midazolam in the Rat J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 347 - 355. [Abstract] [Full Text] |
||||